Outlook Therapeutics, Inc. (OTLK) Cash Flow Annual - Discounting Cash Flows
OTLK
Outlook Therapeutics, Inc.
OTLK (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
09-30
2023
09-30
2022
09-30
2021
09-30
2020
09-30
2019
09-30
2018
09-30
2017
09-30
2016
09-30
2015
09-30
2014
09-30
Report Filing: 2025-05-15 2025-01-23 2024-01-24 2023-01-24 2021-12-23 2020-12-23 2019-12-19 2018-12-18 2018-01-29 2017-01-27 2015-09-30 2014-09-30
Net Income/Starting Line -28,979,569 -75.37 -58.98 -66.05 -53.16 -35.24 -34.52 -46.11 -38.85 -53.33 -48.67 -13.73
Cash From Operating Activities -27,551,109 -68.79 -42.97 -56.67 -54.25 -31.79 -32.29 -33.04 -15.51 -45.48 -27.48 -7.02
Depreciation and Amortization 171,762 0.114 0.044 0.205 0.262 0.554 3.36 -3.05 2.69 2.39 1.82 0.878
Deferred Income Tax 0 0 0 0 0.498 2.24 9.44 20.15 -3.1 0.014 0 0
Stock Based Compensation 5,395,203 5.39 5.55 7.71 4.89 2.81 1.31 1.99 8.57 12.45 11.18 3.96
Other Non-Cash Items -4,138,516 4.09 5.66 3.15 0.342 -0.881 1.31 7.68 4.01 0.013 0.012 0.012
Changes in Working Capital 11.11 -3.02 4.75 -1.68 -7.08 -1.27 -13.19 -13.68 11.16 -7.02 8.18 1.86
Accounts Receivable 0 0 0 0 0 0 0 0 0 0.02 -0.02 0
Inventory -6,713,928 0 0 0 0 0 0 0 0 -0.221 1.09 0
Accounts Payable 3,818,328 1.39 3.08 1.3 -0.198 -1.49 -1.33 -6.71 5.73 -5.33 6.58 -0.096
Deferred Revenue 1.69 -4.41 1.67 -2.98 -6.88 0.22 -11.86 -6.97 5.44 -1.5 0.532 1.96
Other Working Capital 2,895,610 0 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities 0 0 0 0 0 -0.9 -0.437 -2.78 -0.292 -1.1 -8.8 -2.37
Investments in Property Plant and Equipment 0 0 -0 0 0 0 -0.437 -2.78 -0.292 -1.1 -8.8 -2.37
Payments for Acquisitions 0 0 0 0 0 -0.9 0 0 0 0 0 0
Purchases of Securities 0 0 0 0 0 -0.9 0 0 0 0 0 0
Sales and Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0.9 0 0 0 0 0 0
Cash From Financing Activities 20,179,858 60.33 48.97 59.59 56.19 37.21 39.03 34.35 16.63 39.86 43 11.47
Debt Repayment 0.004 -0.004 19.77 -2.32 6.31 0.641 -6.94 -0.991 11.33 -13.34 1.58 4.39
Common Stock Issued 3,158,754 60.33 30.02 62.31 46.3 35.43 45.96 14.7 1.61 53.21 41.25 11.04
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 -0.226 -4.13
Dividends Paid 0 0 0 0 0 0 0 -1,886,945 -16,985 0 0 0
Other Financing Activities 17,021,104 0 -0.824 -0.394 3.59 1.14 0.004 20.65 16,989 -0.006 0.173 7.11
Effect of Forex Changes on Cash 0 0 0 0 0 0 0 0 0 0 0 0
Net Change in Cash 7,556,281 -8.46 6 2.92 1.94 4.52 6.3 -1.47 0.834 -6.72 6.72 2.09
Cash at Beginning of Period 32.02 23.39 17.4 14.48 12.54 8.02 1.72 3.19 2.35 9.07 2.35 0.262
Cash at End of Period 7,556,313 14.93 23.39 17.4 14.48 12.54 8.02 1.72 3.19 2.35 9.07 2.35
Free Cash Flow -27,551,109 -68.79 -42.97 -56.67 -54.25 -31.79 -32.73 -35.82 -15.8 -46.58 -36.28 -9.39
Operating Cash Flow -27,551,109 -68.79 -42.97 -56.67 -54.25 -31.79 -32.29 -33.04 -15.51 -45.48 -27.48 -7.02
Capital Expenditure 0 0 -0 0 0 0 -0.437 -2.78 -0.292 -1.1 -8.8 -2.37
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us